Physician profile
Chad Secor
NPI 1225038177
$3,411.46
in general payments reported to CMS, 2019-2025
16 companies · $1,028 in 2025
The $1,028 reported for 2025 was more than what 80% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119 · 2020: $30.74 · 2021: $33.83 · 2022: $1,189 · 2023: $531 · 2024: $480 · 2025: $1,028.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,981 · Education: $57.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,980.93 |
| Education | $57.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,552.36 | 2022-2025 | Inspire |
| Regeneron Healthcare Solutions, INC. | $455.80 | 2019-2025 | Dupixent |
| Phathom Pharmaceuticals, INC. | $224.74 | 2024-2025 | Voquezna |
| Medtronic, INC. | $217.25 | 2021-2025 | Propel, Pteye Parathyroid Detection System |
| Glaxosmithkline, LLC. | $190.36 | 2023-2025 | Nucala |
| Access Pro Medical, LLC | $144.43 | 2025 | Matriderm |
| Astrazeneca Pharmaceuticals LP | $133.66 | 2025 | Airsupra, Tezspire |
| Optinose US, INC. | $128.22 | 2019-2023 | |
| Stryker Corporation | $76.93 | 2019-2025 | Scopis Ent |
| Integra Lifesciences Corporation | $76.77 | 2024 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Smith+Nephew, INC. | $74.66 | 2023 | Tula |
| Pacira Pharmaceuticals Incorporated | $37.57 | 2022-2023 | Exparel |
| Amgen INC. | $33.33 | 2025 | Tezspire |
| Genzyme Corporation | $32.78 | 2025 | |
| Intersect Ent, INC. | $16.42 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cochlear Americas | $16.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Secor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.